Stay updated on Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page.

Latest updates to the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedEnrollment is shown as closed with the new line 'No longer looking for participants'. The page also adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading.SummaryDifference0.3%

- Check16 days agoChange DetectedRevision: v3.5.5 was added and Revision: v3.5.4 was removed. This signals a small platform update to the page rendering rather than changes to the study details.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing Revision: v3.5.3. This reflects a new page revision applied to the documentation.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page footer shows an updated ClinicalTrials.gov revision identifier from v3.5.2 to v3.5.3, indicating a system/version update without changing the study details.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision label updated to v3.5.0 (from v3.4.3).SummaryDifference0.0%

Stay in the know with updates to Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page.